Most adults use between 0.5 and 5 mg of melatonin per day for sleep, and a recent dose-response meta-analysis found that sleep benefits peak at around 4 mg daily, with higher amounts adding little additional effect. But “how much you can take” and “how much you should take” are different questions, and the gap between them is surprisingly wide. Melatonin has been tested at doses hundreds of times larger than a typical supplement without causing serious harm, yet the dose that actually helps you sleep best may be far lower than what you’re currently swallowing.
What the Research Says About Optimal Sleep Doses
A 2024 systematic review and dose-response meta-analysis of randomized controlled trials found that melatonin gradually reduces the time it takes to fall asleep and increases total sleep time, with benefits peaking at about 4 mg per day.1PubMed. Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response Meta-Analysis Beyond that threshold, additional milligrams did not meaningfully improve sleep. That same analysis suggested that taking melatonin about three hours before your desired bedtime, rather than the commonly recommended 30 minutes, might further improve results.
This 4 mg ceiling contrasts with what many sleep researchers have argued for years. A landmark study from the mid-1990s showed that just 0.3 mg of melatonin raised blood levels into the normal nighttime range and promoted sleep in healthy young adults.2Sleep. Effects of Low Oral Doses of Melatonin, Given 2–4 Hours Before Habitual Bedtime, On Sleep in Normal Young Humans A systematic review focused on older adults similarly advised using the lowest possible dose to mimic the body’s natural melatonin rhythm and avoid keeping blood levels elevated far longer than they would be naturally.3PubMed. Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature
So which is it, 0.3 mg or 4 mg? The honest answer is that it depends on your age, what you’re using melatonin for, and what time you’re taking it. In older adults, whose natural melatonin production has declined, a higher dose like 5 mg significantly increased sleep efficiency during both daytime and nighttime sleep episodes, mainly by extending lighter sleep stages and shortening awakenings.4PubMed Central. High dose melatonin increases sleep duration during nighttime and daytime sleep episodes in older adults For a younger person with a well-functioning pineal gland, a fraction of a milligram may be all that’s needed.
Why Timing Can Matter More Than Dose
One of the most underappreciated findings in melatonin research is that when you take it can outweigh how much you take. A study comparing 0.5 mg and 3.0 mg doses found that when each dose was given at its optimal time, both produced similarly sized shifts in the body’s circadian clock.5PubMed Central. Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg Maximum circadian advances occurred when 0.5 mg was taken in the afternoon, roughly two to four hours before the body’s natural melatonin onset, which for most people translates to mid-to-late afternoon. The lower dose simply needed to be taken a bit later in the window to achieve its peak effect.
This matters because many people who feel melatonin “doesn’t work” are taking it at bedtime, when their own melatonin has already started rising. If you’re trying to shift your sleep schedule earlier, taking melatonin right before bed is like pushing a door that’s already swinging your way. Taking it in the late afternoon or early evening, hours before you plan to sleep, gives the circadian signal time to do its job. For people with delayed sleep-wake phase disorder, 0.5 mg of melatonin taken at an optimal time, combined with behavioral scheduling, shortened the time to fall asleep by roughly 12 to 18 minutes and shifted sleep onset about half an hour earlier compared to placebo.6PLOS Medicine. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial
How High Can You Safely Go?
If you’ve accidentally taken more melatonin than intended, the reassuring reality is that melatonin has an extremely wide safety margin. A systematic review and meta-analysis examining high-dose melatonin studies in adults (doses well above the typical supplement range) found that melatonin did not increase serious adverse events. The main side effects that showed up more than with placebo were drowsiness, headache, and dizziness.7PubMed. Safety of higher doses of melatonin in adults: A systematic review and meta-analysis These are annoyances, not dangers.
In surgical settings, researchers have given a single 50 mg dose of melatonin to patients before major liver surgery. No serious adverse events were attributed to melatonin, and there was actually a trend toward shorter ICU and hospital stays in the melatonin group.8PubMed. The use of high-dose melatonin in liver resection is safe: first clinical experience And a published case report described a patient who took 900 mg of melatonin in an acute overdose. Even at that extraordinary dose, no severe adverse effects occurred beyond sedation, and the patient remained vitally stable.9Sleep Medicine: X. Case report on melatonin overdose: Cause and concern Chronic administration at 1,000 mg daily in adults has also been reported without toxicity.
None of this means you should take enormous doses. The lack of fatal toxicity does not mean the experience is pleasant; common overdose symptoms include significant drowsiness, dizziness, fatigue, headache, confusion, vivid nightmares, low blood pressure, rapid heart rate, and low body temperature.10PubMed Central. Attempted suicide by Melatonin overdose: Case report and literature review The point is that an accidental double or triple dose is unlikely to be medically dangerous, though you’ll probably feel groggy the next morning.
Side Effects That Show Up in Real-World Use
A large pharmacovigilance study using the World Health Organization’s global adverse-event database identified over 35,000 adverse event reports linked to melatonin. The most common reporters were women and adults aged 45 to 64. Beyond the predictable drowsiness and headache, the analysis flagged some signals that don’t get as much attention: nightmares and abnormal dreams were significantly over-reported for melatonin compared to all other drugs, and accidents and injuries (including falls) also came up as disproportionate signals.11PubMed Central. Investigating the safety profiles of exogenous melatonin and associated adverse events: A pharmacovigilance study using WHO-VigiBase The falls and injuries likely reflect the sedation catching people off guard, especially older adults getting up at night.
The dream effects are worth knowing about because vivid, disturbing dreams can be alarming if you don’t expect them. They seem to be a genuine melatonin-specific effect rather than a general sedative effect, since the signal disappeared when melatonin was compared only against other sleep medications rather than all drugs in the database.
Long-Term Use and the Tolerance Question
Many people take melatonin every night for years, so the long-term safety picture matters. A review of chronic melatonin administration found that most research shows no difference between melatonin and placebo in terms of long-term negative effects.12PubMed Central. Chronic Administration of Melatonin: Physiological and Clinical Considerations A separate review of long-term studies came to a similar conclusion but cautioned that the scarcity of rigorous double-blind, placebo-controlled long-term trials means we shouldn’t be fully complacent.13PubMed. Adverse events in long-term studies of exogenous melatonin The data we have is reassuring, but it’s not as thorough as we’d want for something millions of people take nightly.
Unlike many sleep medications, melatonin does not appear to produce classic tolerance, where you need escalating doses for the same effect. But a paradoxical phenomenon has been documented in some patients with intellectual disabilities: the initial good response to melatonin disappeared within a few weeks, and the good response returned only after a significant dose reduction.14PubMed Central. Loss of response to melatonin treatment is associated with slow melatonin metabolism The patients affected tended to metabolize melatonin slowly, meaning the high blood levels from nightly dosing were building up and saturating their receptors. Cutting the dose paradoxically restored the sleep benefit. If melatonin seems to have stopped working for you, this is a reason to try a lower dose before reaching for a higher one.
Children and Melatonin Dosing
Melatonin has become enormously popular for kids, especially after the pandemic brought a wave of sleep problems and mental health difficulties in children and adolescents. Since melatonin is unregulated in the United States and perceived as natural, many parents reach for it freely.15PubMed Central. Melatonin Use in Pediatrics: A Clinical Review on Indications, Multisystem Effects, and Toxicity Pediatric use worldwide has increased significantly over the past several decades, though the safety evidence is thinner than many parents assume. Most of the reassuring safety data comes from studies of children with neurodevelopmental disorders and insomnia, not typically developing kids, and prospective studies on long-term effects are lacking.16PubMed. Melatonin use in the pediatric population: an evolving global concern
The specific concern parents should know about is puberty. A systematic review of adverse effects in children and adolescents found that three studies reported little or no influence on pubertal development after two to four years of melatonin treatment.17PubMed Central. The short-term and long-term adverse effects of melatonin treatment in children and adolescents: a systematic review and GRADE assessment However, when one of those same groups of children was followed for a longer period (an average of about seven years of continuous use), a tendency toward delayed pubertal timing was observed.18The Lancet Regional Health – Europe. Short- and long-term safety of melatonin treatment in children and adolescents with insomnia: a systematic review and GRADE assessment The findings have methodological limitations and aren’t definitive, but they suggest that years of continuous melatonin use during childhood warrants a conversation with a pediatrician rather than casual long-term supplementation.
Pediatric dosing typically starts very low, often 0.5 to 1 mg, and rarely exceeds 3 to 5 mg. But the bigger risk with children isn’t the dose per tablet; it’s accidental ingestion. Melatonin gummies look and taste like candy, and poisoning-center calls related to pediatric melatonin ingestions have spiked in recent years.
The Label Might Be Lying
Before you obsess over finding the perfect milligram dose, you should know that the number on the bottle may be fiction. A 2023 study published in JAMA tested 25 melatonin gummy products sold in the United States and found that the actual melatonin content ranged from 74% to 347% of what the label claimed. Only 3 of the 25 products (12%) contained a quantity of melatonin within 10% of the declared amount.19JAMA. Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US That means a product labeled as 5 mg could contain anywhere from about 3.7 to over 17 mg.
This is a direct consequence of melatonin’s regulatory status. In the United States, melatonin is sold as a dietary supplement, which means manufacturers don’t need to demonstrate accurate labeling to the FDA before selling their product. In many European countries, the situation is quite different: prolonged-release melatonin is typically a prescription medication, and even where immediate-release melatonin is permitted in supplements, the maximum allowed dose can be as low as 2 mg per daily serving. The labeling inaccuracy in the U.S. market makes precise dosing difficult and makes the “start low” advice even more important, since you genuinely don’t know how much you’re getting.
Drug Interactions That Change Your Effective Dose
Your body breaks down melatonin primarily through a liver enzyme called CYP1A2. Anything that slows that enzyme down effectively gives you a larger dose than you swallowed, because the melatonin stays in your blood longer and at higher concentrations. One of the most dramatic examples involves oral contraceptives: a study found that women taking birth control pills had melatonin blood levels four to five times higher than non-users after the same dose, because the pill strongly inhibits CYP1A2.20PubMed. The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C>A polymorphism If you take both, a 3 mg supplement could functionally behave more like 12 to 15 mg inside your body.
An in-vitro screening of drugs commonly taken alongside melatonin found that at pharmacologically relevant concentrations, common medications like diazepam, tamoxifen, and acetaminophen did not significantly impair melatonin metabolism.21PubMed. Potential drug interactions with melatonin That’s good news for the many people who take occasional pain relievers before bed. The most potent interaction identified was with 5-methoxypsoralen, a compound used in certain psoriasis treatments, which substantially blocked melatonin breakdown. Caffeine is also metabolized by CYP1A2, and smoking induces the enzyme (meaning smokers clear melatonin faster and may need slightly more), but these interactions are modest compared to the oral contraceptive effect.
Immediate-Release Versus Sustained-Release Formulations
The choice between immediate-release and sustained-release melatonin can change how you experience the same dose. A crossover study in healthy adults found that sustained-release capsules produced a peak blood level roughly half that of immediate-release capsules, but kept melatonin elevated for much longer, with levels one to three times higher than immediate-release during the four-to-eight-hour window after taking it.22PubMed Central. Comparative Pharmacokinetics of Sustained-Release versus Immediate-Release Melatonin Capsules in Fasting Healthy Adults: A Randomized, Open-Label, Cross-Over Study The half-life of the sustained-release formulation was about five hours, compared to roughly one hour for immediate-release.
Which one suits you depends on your problem. If you have trouble falling asleep but stay asleep fine, immediate-release delivers a quick spike that mimics the body’s natural onset signal. If you fall asleep easily but wake up repeatedly through the night, sustained-release keeps levels elevated longer and may help with sleep maintenance. The systematic review of older adults recommended immediate-release specifically because it avoids keeping blood melatonin at unnaturally high levels throughout the entire night.3PubMed. Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature In Europe, the prescription melatonin product approved for adults over 55 is a 2 mg prolonged-release tablet, reflecting a different philosophy from the high-dose immediate-release products common in U.S. stores.
Effects on Blood Sugar
A side effect that gets almost no attention on supplement labels is melatonin’s impact on blood sugar regulation. A controlled study found that when healthy adults took melatonin in the morning, their glucose response to a standardized oral glucose test nearly tripled in terms of the area under the curve, a measure of total glucose exposure over time. Even in the evening, glucose response increased by more than half compared to placebo.23PubMed Central. Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening The mechanisms differed by time of day: in the morning, melatonin impaired glucose tolerance mainly by reducing insulin release, while in the evening, it reduced insulin sensitivity.
For most healthy people taking a low dose at bedtime, this probably has minimal practical consequence since you’re not eating a large meal immediately after. But for anyone with type 2 diabetes, prediabetes, or gestational diabetes, the interaction between melatonin and glucose metabolism is worth discussing with a doctor, particularly if you’re taking higher doses or if your schedule involves eating close to when you take melatonin. Late-night snacking after a melatonin dose is a combination that could meaningfully worsen your blood sugar control.
Melatonin Beyond Sleep
Researchers have explored high-dose melatonin for conditions well beyond insomnia, including as an adjunct in cancer treatment. Melatonin has antioxidant and immunomodulatory properties, and a growing number of studies have described anticancer effects in laboratory and animal models.24PubMed Central. Use of Melatonin in Cancer Treatment: Where Are We? Doses in these studies often range from 20 mg to several hundred milligrams daily, far beyond anything used for sleep. The clinical evidence for using melatonin in cancer care is still early-stage and not yet strong enough to support routine use, but it’s one reason researchers keep studying the safety of high doses. The surgical study mentioned earlier, using 50 mg before liver surgery, was motivated in part by melatonin’s potential to protect liver tissue from oxidative damage during the procedure.
These non-sleep applications are a reminder that “how much melatonin can you take” has a different answer depending on what you’re trying to accomplish. For sleep, the evidence suggests most people top out their benefit somewhere between 0.5 and 5 mg, with timing and formulation doing as much work as the milligram number. For experimental clinical uses under medical supervision, much higher doses have been administered safely, though this is not a license for self-experimentation. The gulf between what’s safe and what’s useful is a recurring theme in melatonin research, and it cuts both ways: taking too much probably won’t hurt you, but it probably won’t help you sleep any better either.